Helioxanthin derivative 5-4-2 has shown potential in the field of antiviral research, particularly in inhibiting the replication of certain viruses. Its mechanism of action involves targeting viral enzymes or proteins, making it a candidate for developing antiviral therapies. Additionally, it has been explored in cancer research due to its ability to induce apoptosis in specific cancer cell lines, suggesting its role in chemotherapeutic applications. The compound has also been studied for its anti-inflammatory properties, which could be beneficial in treating inflammatory diseases. Ongoing research aims to further understand its efficacy and safety for potential therapeutic use.